0
X-rays and artificial intelligence offer a potential diagnostic tool for COVID-19
Researchers from the Universidade Federal do Ceará, Instituto Federal do Ceará and Universidade de Fortaleza (all Fortaleza, Brazil) report on…
Browsing: News
0
nAbbing SARS-CoV-2 variants
New SARS-CoV-2 variants mean new neutralizing antibodies to deal with them. With the COVID-19 pandemic on its third wave in some…
0
What effect will SARS-CoV-2 variants have on vaccine efficacy?
The ‘inevitable’ domination of novel SARS-CoV-2 variants from Brazil, South Africa and the UK could result in less effective COVID-19…
0
Intellectual – not physical – disability is the second greatest predictor of COVID-19 mortality
New research confirms the suspicions of many caregivers around the globe: those with intellectual disabilities are at a vastly increased risk of catching and dying from…
0
Gender equality in STEM – infographic and podcast
As part of its activities to mark International Women’s Day 2021 (8 March), our parent company, Future Science Group, conducted a survey on…
0
How effective are the COVID-19 vaccines for those who are immunocompromised?
Up to 5000 immunocompromised people from across the UK are set to be vaccinated as part of the Octave study…
0
The impact of the first dose of the COVID-19 vaccines
The first national population-level study has shed light on the effect of the first dose of the COVID-19 vaccine. The…
0
One drug to rule them all?
Thapsigargin, a promising broad-spectrum antiviral, has proven effective for use against SARS-CoV-2, as well as the influenza A and respiratory…
0
Gender equality in STEM: we want to hear your thoughts!
What actions could help promote gender equality in STEM? We want to hear from you: share your thoughts by completing this…
0
Natural immunity to COVID-19: how long and how strong?
Two recent papers from Public Health England (PHE; London, UK) and Rockefeller University (NY, USA) have shed new light on the duration and quality of protection provided…